title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
74 Biggest Movers From Yesterday,20220429T091949,https://www.benzinga.com/news/22/04/26890965/74-biggest-movers-from-yesterday,JAZZ,0.023866,Neutral,0.007378
"Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More",20241121T171300,https://www.zacks.com/stock/news/2373588/biotech-stock-roundup-sage-incy-suffer-setbacks-jazz-wins-oncology-drug-approval-more,JAZZ,0.099683,Neutral,0.062317
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors - Impel Pharmaceuticals  ( NASDAQ:IMPL ) ,20230412T200100,https://www.benzinga.com/pressreleases/23/04/g31776707/impel-pharmaceuticals-announces-appointment-of-darren-cline-to-the-board-of-directors,JAZZ,0.027413,Neutral,0.0082
"Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals  ( NASDAQ:CRBP ) , AbbVie  ( NYSE:ABBV ) ",20240514T173240,https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38803783/will-pharma-and-healthcare-have-competitive-edge-in-cannabis-post-rescheduling-data,JAZZ,0.088964,Neutral,0.0
RedHill  ( RDHL )  Up on Orphan Drug Tag for NTM Disease Drug,20220818T150400,https://www.zacks.com/stock/news/1969750/redhill-rdhl-up-on-orphan-drug-tag-for-ntm-disease-drug,JAZZ,0.228073,Somewhat-Bullish,0.267771
"Gastroenteropancreatic Neuroendocrine Tumors Market to Showcase a Significant Growth by 2032, Evaluates DelveInsight | Key Players - Eli Lilly and Company, Phanes Therapeutics, Camurus AB, Advanced Accelerator Applications, PharmaMar",20240111T220100,https://www.prnewswire.com/news-releases/gastroenteropancreatic-neuroendocrine-tumors-market-to-showcase-a-significant-growth-by-2032-evaluates-delveinsight--key-players---eli-lilly-and-company-phanes-therapeutics-camurus-ab-advanced-accelerator-applications-pharma-302032286.html,JAZZ,0.025139,Neutral,0.019544
53 Biggest Movers From Yesterday,20220408T084938,https://www.benzinga.com/news/22/04/26539460/53-biggest-movers-from-yesterday,JAZZ,0.031907,Neutral,0.009724
38 Stocks Moving In Thursday's Mid-Day Session,20220407T171413,https://www.benzinga.com/news/22/04/26529716/38-stocks-moving-in-thursdays-mid-day-session,JAZZ,0.044051,Neutral,0.005025
Bispecific Antibody Clinical Trial Pipeline Appears Robust With 250+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20230703T210100,https://www.prnewswire.com/news-releases/bispecific-antibody-clinical-trial-pipeline-appears-robust-with-250-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-301868673.html,JAZZ,0.020404,Neutral,0.130751
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,JAZZ,0.019102,Neutral,0.0
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,JAZZ,0.098659,Neutral,0.0
"The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study",20220607T123117,https://www.benzinga.com/general/biotech/22/06/27583701/the-daily-biotech-pulse-veru-seeks-emergency-use-nod-for-covid-19-therapy-vincerx-cuts-workforce-,JAZZ,0.10322,Neutral,0.009977
Akari Therapeutics Announces Key Leadership Appointments - Akari Therapeutics  ( NASDAQ:AKTX ) ,20241218T135129,https://www.benzinga.com/pressreleases/24/12/g42553004/akari-therapeutics-announces-key-leadership-appointments,JAZZ,0.047138,Neutral,0.07564
Akari Therapeutics Announces Key Leadership Appointments,20241218T135100,https://www.globenewswire.com/news-release/2024/12/18/2999072/0/en/Akari-Therapeutics-Announces-Key-Leadership-Appointments.html,JAZZ,0.048969,Neutral,0.075796
"Cannabis Stock Gainers And Losers From August 11, 2023 - CBD Of Denver  ( OTC:CBDD ) , Trees  ( OTC:CANN ) , Flora Growth  ( NASDAQ:FLGC ) , Global Hemp Group  ( OTC:GBHPF ) , Tetra Bio Pharma  ( OTC:TBPMF ) , Greenlane Hldgs  ( NASDAQ:GNLN ) , 22nd Century Group  ( NASDAQ:XXII ) , Delivra Health Brands  ( OTC:DHBUF ) , Grown Rogue International  ( OTC:GRUSF ) , MediPharm Labs  ( OTC:MEDIF ) , Jazz Pharmaceuticals  ( NASDAQ:JAZZ ) , CV Sciences  ( OTC:CVSI ) , Cresco Labs  ( OTC:CRLBF ) , Village Farms Intl  ( NASDAQ:VFF ) , Allied  ( OTC:ALID ) , Stem Holdings  ( OTC:STMH ) , CNBX Pharmaceuticals  ( OTC:CNBX ) , Maple Leaf Green World  ( OTC:MGWFF ) , Leafly Holdings  ( NASDAQ:LFLY ) , Gaby  ( OTC:GABLF ) , Chalice Brands  ( OTC:CHALF ) , Target Group  ( OTC:CBDY ) , Goodness Growth Holdings  ( OTC:GDNSF ) , 1606  ( OTC:CBDW ) , Heritage Cannabis Holding  ( OTC:HERTF ) , MJ Holdings  ( OTC:MJNE ) , WM Tech  ( NASDAQ:MAPS ) , Enveric Biosciences  ( NASDAQ:ENVB ) , Body and Mind  ( OTC:BMMJ ) , TerrAscend  ( OTC:TSNDF ) , C21 Investments  ( OTC:CXXIF ) , Leafbuyer Techs  ( OTC:LBUY ) , Australis Capital  ( OTC:AUSAF ) , Hemp  ( OTC:HEMP ) , Curaleaf Holdings  ( OTC:CURLF ) , Skye Bioscience  ( OTC:SKYE ) , Elixinol Wellness  ( OTC:ELLXF ) , Glass House Brands  ( OTC:GLASF ) , GreenGro Technologies  ( OTC:GRNH ) , InMed Pharmaceuticals  ( NASDAQ:INM ) , StateHouse Hldgs  ( OTC:STHZF ) , Willow Biosciences  ( OTC:CANSF ) , Khiron Life Sciences  ( OTC:KHRNF ) , Entourage Health  ( OTC:ETRGF ) , Incannex Healthcare  ( NASDAQ:IXHL ) , Rocky Mountain High  ( OTC:RMHB ) , Ayr Wellness  ( OTC:AYRWF ) , Rhinomed  ( OTC:RHNMF ) , POSaBIT Systems  ( OTC:POSAF ) , InnoCan Pharma  ( OTC:INNPF ) , MariMed  ( OTC:MRMD ) , Jushi Holdings  ( OTC:JUSHF ) , Silver Spike Investment  ( NASDAQ:SSIC ) , Acreage Holdings  ( OTC:ACRHF ) , Canopy Gwth  ( NASDAQ:CGC ) , iAnthus Capital Hldgs  ( OTC:ITHUF ) , SOL Glb Inv  ( OTC:SOLCF ) , Agrify  ( NASDAQ:AGFY ) , Radient Technologies  ( OTC:RDDTF ) , SLANG Worldwide  ( OTC:SLGWF ) , SciSparc  ( NASDAQ:SPRC ) , CBD Unlimited  ( OTC:EDXC ) , Indiva  ( OTC:NDVAF ) , Ascend Wellness Holdings  ( OTC:AAWH ) , Earth Science Tech  ( OTC:ETST ) , Malachite Innovations  ( OTC:MLCT ) , Decibel Cannabis Co  ( OTC:DBCCF ) , GrowLife  ( OTC:PHOT ) , Clever Leaves Holdings  ( NASDAQ:CLVR ) ",20230811T213009,https://www.benzinga.com/markets/cannabis/23/08/33763780/cannabis-stock-gainers-and-losers-from-august-11-2023,JAZZ,0.096477,Somewhat-Bullish,0.253127
JAZZ Secures FDA Approval for Ziihera in Biliary Tract Cancer,20241121T170800,https://www.zacks.com/stock/news/2373587/jazz-secures-fda-approval-for-ziihera-in-biliary-tract-cancer,JAZZ,0.354572,Neutral,0.114098
CytomX Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update,20230808T201500,https://www.globenewswire.com/news-release/2023/08/08/2721181/37704/en/CytomX-Therapeutics-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html,JAZZ,0.017955,Neutral,0.049295
Zymeworks Appoints New Director - Zymeworks  ( NASDAQ:ZYME ) ,20230629T200500,https://www.benzinga.com/pressreleases/23/06/g33066902/zymeworks-appoints-new-director,JAZZ,0.032294,Neutral,0.063641
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,JAZZ,0.043778,Neutral,0.034443
LAVA Therapeutics Provides Business Update and Reports First Quarter 2023 Financial Results,20230608T110000,https://www.globenewswire.com/news-release/2023/06/08/2684602/0/en/LAVA-Therapeutics-Provides-Business-Update-and-Reports-First-Quarter-2023-Financial-Results.html,JAZZ,0.055621,Neutral,0.097013
LAVA Therapeutics Announces Appointment of Fred M. Powell as Chief Financial Officer,20221101T110000,https://www.globenewswire.com/news-release/2022/11/01/2545292/0/en/LAVA-Therapeutics-Announces-Appointment-of-Fred-M-Powell-as-Chief-Financial-Officer.html,JAZZ,0.073546,Neutral,0.016266
LAVA Therapeutics Announces Two Appointments to its Board of Directors,20220615T110000,https://www.globenewswire.com/news-release/2022/06/15/2462948/0/en/LAVA-Therapeutics-Announces-Two-Appointments-to-its-Board-of-Directors.html,JAZZ,0.038059,Neutral,0.015462
LAVA Therapeutics Announces Two Appointments to its Board of Directors,20220615T110000,https://www.benzinga.com/pressreleases/22/06/g27715260/lava-therapeutics-announces-two-appointments-to-its-board-of-directors,JAZZ,0.036694,Neutral,0.015462
"Earnings Scheduled For May 4, 2022",20220504T083630,https://www.benzinga.com/news/earnings/22/05/26983503/earnings-scheduled-for-may-4-2022,JAZZ,0.010898,Neutral,-0.00094
"Canopy Growth, Avadel Pharmaceuticals And Other Big Stocks Moving Lower On Friday - Avadel Pharmaceuticals  ( NASDAQ:AVDL ) , C3.ai  ( NYSE:AI ) ",20230623T143343,https://www.benzinga.com/news/23/06/32985326/canopy-growth-avadel-pharmaceuticals-and-other-big-stocks-moving-lower-on-friday,JAZZ,0.15347,Neutral,-0.113167
"Ligand's  ( LGND )  Q4 Sales & Earnings Top, View Raised, Stock Up",20230223T124900,https://www.zacks.com/stock/news/2057948/ligands-lgnd-q4-sales-earnings-top-view-raised-stock-up,JAZZ,0.088964,Neutral,0.080588
